Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 07, 2021 Filed Jun 9, 2021 16:25 UTC |
George Robert E.Director
|
GrantStock option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $3.95 | Not disclosed |
DisclosureSEC source: 0001437749-21-014426 · rdgdoc.xml · derivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,668 Underlying: Common Stock · 10,000 shares Expires 2031-06-07 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:26 UTC |
CANNON MICHAEL DDirector
|
GrantStock option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $3.95 | Not disclosed |
DisclosureSEC source: 0001437749-21-014429 · rdgdoc.xml · derivative · entry 1 CANNON MICHAEL D · CIK 0001203602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,668 Underlying: Common Stock · 10,000 shares Expires 2031-06-07 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:26 UTC |
Cermak ElizabethDirector
|
GrantStock option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $3.95 | Not disclosed |
DisclosureSEC source: 0001437749-21-014428 · rdgdoc.xml · derivative · entry 1 Cermak Elizabeth · CIK 0001471971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,667 Underlying: Common Stock · 10,000 shares Expires 2031-06-07 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 20:25 UTC |
Climaco John MDirector
|
GrantStock option (right to buy) · Derivative | 10,000 | Not disclosed Strike: $3.95 | Not disclosed |
DisclosureSEC source: 0001437749-21-014427 · rdgdoc.xml · derivative · entry 1 Climaco John M · CIK 0001546797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,168 Underlying: Common Stock · 10,000 shares Expires 2031-06-07 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| October 02, 2020 Filed Oct 5, 2020 21:26 UTC |
Cermak ElizabethDirector
|
GrantStock option (right to buy) · Derivative | 40,000 | Not disclosed Strike: $0.81 | Not disclosed |
DisclosureSEC source: 0001437749-20-020742 · rdgdoc.xml · derivative · entry 1 Cermak Elizabeth · CIK 0001471971 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2030-10-02 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 20:04 UTC |
Priebe Waldemar10% owner
|
GrantStock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.96 | Not disclosed |
DisclosureSEC source: 0001659617-20-000206 · wf-form4_159829941790393.xml · derivative · entry 1 Priebe Waldemar · CIK 0001678516 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-08-20 F2 · price: Issued in connection with the reporting person providing services to the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 13, 2020 Filed Jul 14, 2020 22:03 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 79,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001659617-20-000178 · wf-form4_159476421761509.xml · derivative · entry 3 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,430,891 Underlying: Common Stock · 79,227 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On July 11, 2019, the reporting person was granted 316,907 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On July 11, 2019, the reporting person was granted 316,907 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| July 13, 2020 Filed Jul 14, 2020 22:03 UTC |
KLEMP WALTER VDirector · CEO and President
|
Tax withholdingCommon Stock | 19,292 | $0.86 | $16,513.95 |
DisclosureSEC source: 0001659617-20-000178 · wf-form4_159476421761509.xml · nonDerivative · entry 2 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,027,659 F2 · shares: Shares withheld for payment of taxes upon vesting of restricted stock unit awards. Read SEC document |
| July 13, 2020 Filed Jul 14, 2020 22:03 UTC |
KLEMP WALTER VDirector · CEO and President
|
Exercise / conversionCommon Stock | 79,227 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001659617-20-000178 · wf-form4_159476421761509.xml · nonDerivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,046,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:24 UTC |
KLEMP WALTER VDirector · CEO and President
|
GrantRestricted Stock Units · Derivative | 353,211 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001659617-20-000173 · wf-form4_159415661342622.xml · derivative · entry 2 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,510,118 Underlying: Common Stock · 353,211 shares Expires not disclosed F3 · derivative.exercise_price: (3) Each restricted stock unit represents a contingent right to receive one share of Company common stock. F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: (4) The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. F4 · derivative.expiration_date: (4) The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:24 UTC |
KLEMP WALTER VDirector · CEO and President
|
GrantStock option (right to buy) · Derivative | 500,000 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001659617-20-000173 · wf-form4_159415661342622.xml · derivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,156,907 Underlying: Common Stock · 500,000 shares Expires 2030-07-02 F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:14 UTC |
Foster Jonathan P.Exec. Vice President and CFO
|
GrantStock option (right to buy) · Derivative | 460,000 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001659617-20-000172 · wf-form4_159415646381168.xml · derivative · entry 1 Foster Jonathan P. · CIK 0001545414 · Exec. Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,621,000 Underlying: Common Stock · 460,000 shares Expires 2030-07-02 F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 21:13 UTC |
PICKER DONALD HChief Science Officer
|
GrantStock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $0.93 | Not disclosed |
DisclosureSEC source: 0001659617-20-000171 · wf-form4_159415638537678.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,000 Underlying: Common Stock · 100,000 shares Expires 2030-07-02 F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 16:30 UTC |
George Robert E.Director
|
GrantStock option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $1.12 | Not disclosed |
DisclosureSEC source: 0001659617-20-000151 · wf-form4_159242581160556.xml · derivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-16 F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors in each vesting date. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 20:34 UTC |
CANNON MICHAEL DDirector
|
GrantStock option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $1.12 | Not disclosed |
DisclosureSEC source: 0001659617-20-000153 · wf-form4_159242604415421.xml · derivative · entry 1 CANNON MICHAEL D · CIK 0001203602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-15 F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors in each vesting date. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 20:32 UTC |
Climaco John MDirector
|
GrantStock option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $1.12 | Not disclosed |
DisclosureSEC source: 0001659617-20-000152 · wf-form4_159242592252592.xml · derivative · entry 1 Climaco John M · CIK 0001546797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 15,000 shares Expires 2030-06-15 F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors in each vesting date. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 20:21 UTC |
KLEMP WALTER VDirector · CEO and President
|
GrantRestricted Stock Units · Derivative | 316,907 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001659617-19-000105 · wf-form4_156322208980596.xml · derivative · entry 2 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,656,907 Underlying: Common Stock · 316,907 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Company common stock. F2 · price: Issued in connection with the reporting person's employment with the Company. F4 · derivative.exercise_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. F4 · derivative.expiration_date: The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 20:21 UTC |
KLEMP WALTER VDirector · CEO and President
|
GrantStock option (right to buy) · Derivative | 500,000 | Not disclosed Strike: $1.31 | Not disclosed |
DisclosureSEC source: 0001659617-19-000105 · wf-form4_156322208980596.xml · derivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,340,000 Underlying: Common Stock · 500,000 shares Expires 2029-07-11 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 16:17 UTC |
George Robert E.Director
|
GrantStock option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $1.31 | Not disclosed |
DisclosureSEC source: 0001659617-19-000104 · wf-form4_156322181376648.xml · derivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 35,000 shares Expires 2029-07-11 F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 20:25 UTC |
CANNON MICHAEL DDirector
|
GrantStock option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $1.31 | Not disclosed |
DisclosureSEC source: 0001659617-19-000107 · wf-form4_156322231160782.xml · derivative · entry 1 CANNON MICHAEL D · CIK 0001203602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 35,000 shares Expires 2029-07-11 F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 20:14 UTC |
Climaco John MDirector
|
GrantStock option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $1.31 | Not disclosed |
DisclosureSEC source: 0001659617-19-000103 · wf-form4_156322163353261.xml · derivative · entry 1 Climaco John M · CIK 0001546797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 35,000 shares Expires 2029-07-11 F2 · price: (2) The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: (1) The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 20:06 UTC |
PICKER DONALD HChief Science Officer
|
GrantStock option (right to buy) · Derivative | 100,000 | Not disclosed Strike: $1.31 | Not disclosed |
DisclosureSEC source: 0001659617-19-000102 · wf-form4_156322120093753.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Underlying: Common Stock · 100,000 shares Expires 2029-07-11 F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| July 11, 2019 Filed Jul 15, 2019 20:04 UTC |
Foster Jonathan P.Exec. Vice President and CFO
|
GrantStock option (right to buy) · Derivative | 315,000 | Not disclosed Strike: $1.31 | Not disclosed |
DisclosureSEC source: 0001659617-19-000101 · wf-form4_156322106686428.xml · derivative · entry 1 Foster Jonathan P. · CIK 0001545414 · Exec. Vice President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,161,000 Underlying: Common Stock · 315,000 shares Expires 2029-07-11 F2 · price: (2) Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: (1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 17:00 UTC |
George Robert E.Director
|
GrantStock option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0001144204-19-028195 · tv522431_4.xml · derivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 15,000 shares Expires 2029-05-22 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 21:00 UTC |
Climaco John MDirector
|
GrantStock option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0001144204-19-028197 · tv522433_4.xml · derivative · entry 1 Climaco John M · CIK 0001546797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 15,000 shares Expires 2029-05-22 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 21:00 UTC |
CANNON MICHAEL DDirector
|
GrantStock option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $1.15 | Not disclosed |
DisclosureSEC source: 0001144204-19-028196 · tv522432_4.xml · derivative · entry 1 CANNON MICHAEL D · CIK 0001203602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 15,000 shares Expires 2029-05-22 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in four quarterly installments, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 21:24 UTC |
KLEMP WALTER VDirector · CEO and President
|
GrantStock option (right to buy) · Derivative | 603,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001144204-18-033605 · tv496089_4.xml · derivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 943,000 Underlying: Common stock · 603,000 shares Expires 2028-06-06 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 17:25 UTC |
George Robert E.Director
|
GrantStock option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001144204-18-033607 · tv496091_4.xml · derivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 35,000 shares Expires 2028-06-06 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 21:27 UTC |
Climaco John MDirector
|
GrantStock option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001144204-18-033609 · tv496093_4.xml · derivative · entry 1 Climaco John M · CIK 0001546797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,000 Underlying: Common Stock · 35,000 shares Expires 2028-06-06 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Companya(euro)(TM)s Board of Directors on each vesting date. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 21:27 UTC |
CANNON MICHAEL DDirector
|
GrantStock option (right to buy) · Derivative | 35,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001144204-18-033610 · tv496094_4.xml · derivative · entry 1 CANNON MICHAEL D · CIK 0001203602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 35,000 shares Expires 2028-06-06 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 21:25 UTC |
PICKER DONALD HChief Science Officer
|
GrantStock option (right to buy) · Derivative | 75,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001144204-18-033608 · tv496092_4.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Underlying: Common stock · 75,000 shares Expires 2028-06-06 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 21:24 UTC |
Foster Jonathan P.Chief Financial Officer
|
GrantStock option (right to buy) · Derivative | 301,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001144204-18-033606 · tv496090_4.xml · derivative · entry 1 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 846,000 Underlying: Common stock · 301,000 shares Expires 2028-06-06 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| June 06, 2018 Filed Jul 15, 2019 20:22 UTC Amendment |
KLEMP WALTER VDirector · CEO and President
|
GrantStock option (right to buy) · Derivative | 500,000 | Not disclosed Strike: $1.82 | Not disclosed |
DisclosureSEC source: 0001659617-19-000106 · wf-form4a_156322215943382.xml · derivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 840,000 Underlying: Common Stock · 500,000 shares Expires 2028-06-06 F1 · shares: As previously reported on a Form 4 filed on June 8, 2018 by the reporting person, the reporting person reported acquiring stock options to purchase 603,000 shares of common stock. However, the Company subsequently determined that stock options to purchase 103,000 shares of common stock under the Company's 2015 Stock Plan were not validly granted pursuant to the plan because they exceeded the limit on the number of stock options that may be granted to any individual participant one year period. Accordingly, the attempted grant of these excess stock options was ineffective, and they were never granted to the reporting person. The reporting person is filing this amendment to report the correct amount of stock options acquired, and to revise the vesting schedule for the stock options to provide that 150,750 options vested as of June 6, 2019, and the remaining options shall vest in three equal installments on June 6, 2020, 2021, and 2022. F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: As previously reported on a Form 4 filed on June 8, 2018 by the reporting person, the reporting person reported acquiring stock options to purchase 603,000 shares of common stock. However, the Company subsequently determined that stock options to purchase 103,000 shares of common stock under the Company's 2015 Stock Plan were not validly granted pursuant to the plan because they exceeded the limit on the number of stock options that may be granted to any individual participant one year period. Accordingly, the attempted grant of these excess stock options was ineffective, and they were never granted to the reporting person. The reporting person is filing this amendment to report the correct amount of stock options acquired, and to revise the vesting schedule for the stock options to provide that 150,750 options vested as of June 6, 2019, and the remaining options shall vest in three equal installments on June 6, 2020, 2021, and 2022. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 21:59 UTC |
KLEMP WALTER VDirector · CEO · 10% owner
|
GrantStock option (right to buy) · Derivative | 340,000 | Not disclosed Strike: $2.49 | Not disclosed |
DisclosureSEC source: 0001144204-17-051543 · v476495_4.xml · derivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,000 Underlying: Common stock · 340,000 shares Expires 2027-10-03 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 22:04 UTC |
PICKER DONALD HChief Science Officer
|
GrantStock option (right to buy) · Derivative | 60,000 | Not disclosed Strike: $2.49 | Not disclosed |
DisclosureSEC source: 0001144204-17-051549 · v476494_4.xml · derivative · entry 1 PICKER DONALD H · CIK 0001266800 · Chief Science Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common stock · 60,000 shares Expires 2027-10-03 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 22:02 UTC |
Foster Jonathan P.Chief Financial Officer
|
GrantStock option (right to buy) · Derivative | 145,000 | Not disclosed Strike: $2.49 | Not disclosed |
DisclosureSEC source: 0001144204-17-051545 · v476493_4.xml · derivative · entry 1 Foster Jonathan P. · CIK 0001545414 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,000 Underlying: Common stock · 145,000 shares Expires 2027-10-03 F2 · price: Issued in connection with the reporting person's employment with the Company. F1 · derivative.exercise_date: The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 22:01 UTC |
KLEMP WALTER VDirector · Chief Executive Officer · 10% owner
|
SaleCommon Stock | 100,000 | $1.70 | $170,300.00 |
DisclosureSEC source: 0001144204-17-044233 · v473535_4.xml · nonDerivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967,724 F1 · kind: The reporting person entered into a private sale agreement for the shares of common stock set forth in the table. The 12,000 shares of common stock purchased by the reporting person on May 11, 2017 are a matching transaction under Section 16 of the Securities Exchange Act of 1934 with 12,000 shares of common stock sold by the reporting person as set forth in the table above. In Accordance with Section 16, the reporting person will disgorge to the issuer an aggregate short-swing profit of $10,716. F2 · balance_after: In addition to the shares held directly by the reporting person, the reporting person is the majority shareholder and control person of Annamed, Inc. Annamed, Inc. holds 1,425,000 shares of Issuer common stock. The Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc. Read SEC document |
| August 16, 2017 Filed Aug 18, 2017 22:00 UTC |
Priebe Waldemar10% owner
|
SaleCommon Stock | 100,000 | $1.70 | $170,300.00 |
DisclosureSEC source: 0001144204-17-044232 · v473534_4.xml · nonDerivative · entry 1 Priebe Waldemar · CIK 0001678516 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,781,573 F1 · kind: The reporting person entered into a private sale agreement for the shares of common stock set forth in the table. F2 · balance_after: In addition to the shares held directly by the reporting person, The reporting person is a shareholder and control person of IntertechBio Corp. IntertechBio Corp. holds 630,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by IntertechBio Corp. The reporting person is also a shareholder and control person of Houston Pharmaceuticals, Inc. Houston Pharmaceuticals, Inc. holds 629,000 shares of Issuer common stock. Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Houston Pharmaceuticals, Inc. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 21:08 UTC |
George Robert E.Director
|
GrantOption to purchase common stock · Derivative | 15,000 | Not disclosed Strike: $1.87 | Not disclosed |
DisclosureSEC source: 0001144204-17-038497 · v471464_4.xml · derivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 15,000 shares Expires 2027-07-24 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| July 24, 2017 Filed Jul 27, 2017 01:06 UTC |
Climaco John MDirector
|
GrantOption to purchase common stock · Derivative | 20,000 | Not disclosed Strike: $1.87 | Not disclosed |
DisclosureSEC source: 0001144204-17-038495 · v471461_4.xml · derivative · entry 1 Climaco John M · CIK 0001546797 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-07-24 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| July 24, 2017 Filed Jul 27, 2017 01:10 UTC |
CANNON MICHAEL DDirector
|
GrantOption to purchase common stock · Derivative | 15,000 | Not disclosed Strike: $1.87 | Not disclosed |
DisclosureSEC source: 0001144204-17-038499 · v471463_4.xml · derivative · entry 1 CANNON MICHAEL D · CIK 0001203602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 15,000 shares Expires 2027-07-24 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| May 11, 2017 Filed May 12, 2017 21:19 UTC |
KLEMP WALTER VDirector · Chief Executive Officer · 10% owner
|
PurchaseCommon Stock | 12,000 | $0.81 | $9,720.00 |
DisclosureSEC source: 0001144204-17-026954 · v466826_form4.xml · nonDerivative · entry 1 KLEMP WALTER V · CIK 0000938419 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,067,724 F1 · balance_after: In addition to the shares held directly by the reporting person, the reporting person is the majority shareholder and control person of Annamed, Inc. Annamed, Inc. holds 1,425,000 shares of Issuer common stock. The Pursuant to General Instruction 5(b)(iv) of Form 3, the amount set forth in the table represents the reporting person's proportionate interest in the Issuer common stock beneficially owned by Annamed, Inc. Read SEC document |
| May 05, 2017 Filed May 5, 2017 16:30 UTC |
Northcut JacquelineDirector
|
PurchaseCommon Stock | 1,000 | $0.82 | $820.00 |
DisclosureSEC source: 0001144204-17-024864 · v466235_4.xml · nonDerivative · entry 1 Northcut Jacqueline · CIK 0001674644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| April 28, 2017 Filed Apr 28, 2017 16:31 UTC |
George Robert E.Director
|
PurchaseCommon Stock | 1,000 | $0.94 | $938.40 |
DisclosureSEC source: 0001144204-17-023240 · v465565_4.xml · nonDerivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| April 25, 2017 Filed Apr 26, 2017 20:30 UTC |
Foster Jonathan P.Exec. Vice President & CFO
|
PurchaseCommon Stock | 10,000 | $0.86 | $8,649.00 |
DisclosureSEC source: 0001144204-17-022289 · v465197_form4.xml · nonDerivative · entry 1 Foster Jonathan P. · CIK 0001545414 · Exec. Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 20:58 UTC |
Northcut JacquelineDirector
|
GrantOption to purchase common stock · Derivative | 20,000 | Not disclosed Strike: $5.71 | Not disclosed |
DisclosureSEC source: 0001144204-16-125634 · v449473_4.xml · derivative · entry 1 Northcut Jacqueline · CIK 0001674644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-23 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 20:58 UTC |
George Robert E.Director
|
GrantOption to purchase common stock · Derivative | 20,000 | Not disclosed Strike: $5.71 | Not disclosed |
DisclosureSEC source: 0001144204-16-125633 · v449472_4.xml · derivative · entry 1 George Robert E. · CIK 0001674701 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-23 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
| September 23, 2016 Filed Sep 28, 2016 00:58 UTC |
CANNON MICHAEL DDirector
|
GrantOption to purchase common stock · Derivative | 20,000 | Not disclosed Strike: $5.71 | Not disclosed |
DisclosureSEC source: 0001144204-16-125635 · v449474_4.xml · derivative · entry 1 CANNON MICHAEL D · CIK 0001203602 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2026-09-23 F2 · price: The options were issued in connection with the reporting person's Board of Director service to the Company. F1 · derivative.exercise_date: The options set forth in this table vest in three equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service on the Company's Board of Directors on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.